European Stroke Organisation (ESO) guideline on pharmacological interventions for long-term secondary prevention after ischaemic stroke or transient ischaemic attack

Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

(2021) Kazem Rahimi et al.   LANCET

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

(2021) Frank L J Visseren et al.   EUROPEAN HEART JOURNAL

The Impact of Cognitive Function on the Effectiveness and Safety of Intensive Blood Pressure Control for Patients With Hypertension: A post-hoc Analysis of SPRINT

(2021) Jiafu Yan et al.   Frontiers in Cardiovascular Medicine

Rivaroxaban in Peripheral Artery Disease after Revascularization

(2020) Marc P. Bonaca et al.   NEW ENGLAND JOURNAL OF MEDICINE

Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis

(2020) Robert P. Giugliano et al.   STROKE

Current characteristics and early functional outcome of older stroke patients: a population-based study (Dijon Stroke Registry)

(2020) Yannick Béjot et al.   AGE AND AGEING

Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

(2020) Ken Okumura et al.   NEW ENGLAND JOURNAL OF MEDICINE

Stroke Outcomes in the Cardiovascular OutcoMes for People using Anticoagulation StrategieS (COMPASS) Trial

(2019) Mukul Sharma et al.   CIRCULATION

Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study

(2019) Sarah T Pendlebury et al.   LANCET NEUROLOGY

Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source

(2019) Hans-Christoph Diener et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antiplatelet Therapy After Noncardioembolic Stroke

(2019) Jacoba P. Greving et al.   STROKE

Effect of Standard vs Intensive Blood Pressure Control on the Risk of Recurrent Stroke

(2019) Kazuo Kitagawa et al.   JAMA Neurology

RoB 2: a revised tool for assessing risk of bias in randomised trials

(2019) Jonathan A C Sterne et al.   BMJ-British Medical Journal

Association Between Low-Dose Rivaroxaban With or Without Aspirin and Ischemic Stroke Subtypes

(2019) Kanjana S. Perera et al.   JAMA Neurology

Influence of Pre-Existing Mild Cognitive Impairment and Dementia on Post-Stroke Mortality. The Dijon Stroke Registry

(2019) Mathilde Graber et al.   NEUROEPIDEMIOLOGY

A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke

(2019) Pierre Amarenco et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES

(2019) J. Wouter Jukema et al.   CIRCULATION

Heart Failure After Ischemic Stroke or TIA in Insulin-Resistant Patients Without Diabetes Treated with Pioglitazone

(2018) Lawrence H. Young et al.   CIRCULATION

Intensive blood pressure control may not be safe in subacute ischemic stroke by intracranial atherosclerosis

(2018) Jong-Moo Park et al.   JOURNAL OF HYPERTENSION

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

(2018) Sonia S Anand et al.   LANCET

Desirable Low-Density Lipoprotein Cholesterol Levels for Preventing Stroke Recurrence

(2018) Naohisa Hosomi et al.   STROKE

Pioglitazone and bladder cancer risk: a systematic review and meta-analysis

(2018) Huilin Tang et al.   Cancer Medicine

Does self-monitoring and self-management of blood pressure after stroke or transient ischemic attack improve control? TEST-BP, a randomized controlled trial

(2018) William J. Davison et al.   AMERICAN HEART JOURNAL

2018 ESC/ESH Guidelines for the management of arterial hypertension

(2018) Bryan Williams et al.   EUROPEAN HEART JOURNAL

The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods

(2018) Hooman Kamel et al.   International Journal of Stroke

Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease

(2018) Faiez Zannad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

(2018) Gregory G. Schwartz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

(2017) Marc S. Sabatine et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

(2017) John W. Eikelboom et al.   NEW ENGLAND JOURNAL OF MEDICINE

Self-monitoring of blood pressure in hypertension: A systematic review and individual patient data meta-analysis

(2017) Katherine L. Tucker et al.   PLOS MEDICINE

Combination Therapy Is Superior to Sequential Monotherapy for the Initial Treatment of Hypertension: A Double‐Blind Randomized Controlled Trial

(2017) Thomas M. MacDonald et al.   Journal of the American Heart Association

Using quality assessment tools to critically appraise ageing research: a guide for clinicians

(2016) Jennifer Kirsty Harrison et al.   AGE AND AGEING

The Effect of Intensive vs. Usual Blood Pressure Control on Kidney Function Among Persons With Prior Lacunar Stroke: A Post-Hoc Analysis of the SPS3 Randomized Trial

(2016) Carmen A. Peralta et al.   CIRCULATION

Blood Pressure Reduction and Secondary Stroke PreventionNovelty and Significance

(2016) Aristeidis H. Katsanos et al.   HYPERTENSION

Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials

(2016) Peter M Rothwell et al.   LANCET

One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke

(2016) Pierre Amarenco et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pioglitazone after Ischemic Stroke or Transient Ischemic Attack

(2016) Walter N. Kernan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Epidemiology of stroke in Europe and trends for the 21st century

(2016) Yannick Béjot et al.   PRESSE MEDICALE

Pioglitazone for Secondary Stroke Prevention

(2016) Meng Lee et al.   STROKE

Different systolic blood pressure targets for people with history of stroke or transient ischaemic attack: PAST-BP (Prevention After Stroke—Blood Pressure) randomised controlled trial

(2016) Jonathan Mant et al.   BMJ-British Medical Journal

Different systolic blood pressure targets for people with history of stroke or transient ischaemic attack: PAST-BP (Prevention After Stroke—Blood Pressure) randomised controlled trial

(2016) Jonathan Mant et al.   BMJ-British Medical Journal

Interventions to Improve Medication Adherence in Hypertensive Patients: Systematic Review and Meta-analysis

(2015) Vicki S. Conn et al.   CURRENT HYPERTENSION REPORTS

Effects of Pioglitazone for Secondary Stroke Prevention in Patients with Impaired Glucose Tolerance and Newly Diagnosed Diabetes: The J-SPIRIT Study

(2015) Ryota Tanaka et al.   Journal of Atherosclerosis and Thrombosis

Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study

(2015) Linxin Li et al.   LANCET NEUROLOGY

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

(2015) Christopher P. Cannon et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Japan Statin Treatment Against Recurrent Stroke (J-STARS): A Multicenter, Randomized, Open-label, Parallel-group Study

(2015) Naohisa Hosomi et al.   EBioMedicine

Combination therapy of hypertension in the elderly: a subgroup analysis of the Combination of OLMesartan and a calcium channel blocker or diuretic in Japanese elderly hypertensive patients trial

(2014) Toshio Ogihara et al.   HYPERTENSION RESEARCH

European Stroke Organisation (ESO) Guidelines for the Management of Spontaneous Intracerebral Hemorrhage

(2014) Thorsten Steiner et al.   International Journal of Stroke

Effect of Self-monitoring and Medication Self-titration on Systolic Blood Pressure in Hypertensive Patients at High Risk of Cardiovascular Disease

(2014) Richard J. McManus et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A Polypill Strategy to Improve Adherence

(2014) José M. Castellano et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Control of main risk factors after ischaemic stroke across Europe: data from the stroke-specific module of the EUROASPIRE III survey

(2014) Peter U Heuschmann et al.   European Journal of Preventive Cardiology

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

(2013)   LANCET

Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial

(2013)   LANCET

Home blood pressure monitoring with nurse-led telephone support among patients with hypertension and a history of stroke: a community-based randomized controlled trial

(2012) S. M. Kerry et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Initial Monotherapy and Combination Therapy and Hypertension Control the First Year

(2012) Brent M. Egan et al.   HYPERTENSION

Effects of Clopidogrel Added to Aspirin in Patients with Recent Lacunar Stroke

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

Meta-Analysis

(2011) Ian M. Kronish et al.   CIRCULATION

Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial

(2011) J. Oldgren et al.   EUROPEAN HEART JOURNAL

Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension

(2011) Masunori Matsuzaki et al.   JOURNAL OF HYPERTENSION

Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): a randomised, parallel-group trial

(2011) Morris J Brown et al.   LANCET

Rivaroxaban in Patients with a Recent Acute Coronary Syndrome

(2011) Jessica L. Mega et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of intensive glucose control on incidence of cardiovascular events in patients with type 2 diabetes: A meta-analysis

(2010) Chun-Yu Zhang et al.   ANNALS OF MEDICINE

GRADE guidelines: A new series of articles in the Journal of Clinical Epidemiology

(2010) Gordon H. Guyatt et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Reduced discontinuation of antihypertensive treatment by two-drug combination as first step. Evidence from daily life practice

(2010) Giovanni Corrao et al.   JOURNAL OF HYPERTENSION

Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis

(2010) Alastair JS Webb et al.   LANCET

Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study

(2010) Martin J O'Donnell et al.   LANCET

Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study

(2010) Craig J Currie et al.   LANCET

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

(2010)   LANCET

Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials

(2009) David S. Wald et al.   AMERICAN JOURNAL OF MEDICINE

Safety and Tolerability of Pioglitazone in High-Risk Patients with Type 2 Diabetes

(2009) John Dormandy et al.   DRUG SAFETY

Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial

(2009) JL Mega et al.   LANCET

Cardiovascular Outcomes in Trials of Oral Diabetes Medications

(2008) Elizabeth Selvin et al.   ARCHIVES OF INTERNAL MEDICINE

Treatment of Hypertension in Patients 80 Years of Age or Older

(2008) Nigel S. Beckett et al.   NEW ENGLAND JOURNAL OF MEDICINE

Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke

(2008) Ralph L. Sacco et al.   NEW ENGLAND JOURNAL OF MEDICINE

Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events

(2008) Salim Yusuf et al.   NEW ENGLAND JOURNAL OF MEDICINE

Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Effects of Intensive Glucose Lowering in Type 2 Diabetes

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients

(2008) Kenneth Jamerson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes

(2008) William Duckworth et al.   NEW ENGLAND JOURNAL OF MEDICINE

Statin Treatment and the Occurrence of Hemorrhagic Stroke in Patients With a History of Cerebrovascular Disease

(2008) Mervyn D.I. Vergouwen et al.   STROKE

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

(2008) Gordon H Guyatt et al.   BMJ-British Medical Journal